# Effective dean vortex separation at reduced flow rates towards rare cell sorting

**Authors:** Emma Dupont, Lionel Artinyan, Céline Brunin, Marie Piecyk, Léa Payen, Emmanuelle Laurenceau, Gilles Simon, Jérôme Degouttes, Damien Le Roy, Anne-Laure Deman

PMC · DOI: 10.1038/s41598-026-40845-4 · 2026-02-25

## TL;DR

A spiral microfluidic device was designed to efficiently sort particles and cells at low flow rates, enabling better integration and performance in biological applications.

## Contribution

A low-flow-rate spiral microfluidic device was developed and validated for efficient rare cell sorting.

## Key findings

- The spiral design achieved efficient size-based sorting of 10 and 15 μm microbeads at 50 mL/h.
- The system removed 89% of white blood cells while maintaining over 75% recovery of CTC-mimicking cells.
- Combined experimental and theoretical analysis validated the influence of geometry and flow on sorting efficiency.

## Abstract

The study focuses on the design of a spiral microfluidic device, aiming to efficiently sort particle by size, at tailored flow rate for downstream processing. While spiral devices exploiting Dean vortices are recognized for their high-throughput capabilities, they often require high flow rates that limit their integration with other microfluidic functions and reduce sorting performance. Our work aims to design a low flowrate-operating-spiral (~ 50 mL/h) by investigating the influence of spiral geometric parameters and flow conditions on sorting efficiency. Through combined experimental and theoretical analysis, we evaluate how particle size and flow dynamics determine particle positions within the spiral, validating underlying models. This approach provides valuable insights for optimizing spiral microfluidic systems particularly their design, performance, and versatility in applications such as the isolation of rare cell isolation. The spiral design achieved efficient size-based sorting of 10 and 15 μm microbeads at a flow rate of 50 mL/h. When applied to biological samples, the system removed 89% of white blood cells from a 1:1 lysed blood sample (≈ 10⁷ cells/min) while maintaining a recovery of more than 75% for all tested CTC-mimicking cells.

The online version contains supplementary material available at 10.1038/s41598-026-40845-4.

## Full-text entities

- **Diseases:** Cancer (MESH:D009369), breast cancer (MESH:D001943)
- **Chemicals:** Silicone (MESH:D012828), Hoechst (-), polystyrene (MESH:D011137), EDTA (MESH:D004492), water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PC3 prostate cancer — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_M124), HCC827 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_2063), MDA — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_4747), PC3 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0035), MCF7 breast cancer — Homo sapiens (Human), Transformed cell line (CVCL_WC49), MCF7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13031336/full.md

---
Source: https://tomesphere.com/paper/PMC13031336